学术探索
学术期刊
新闻热点
数据分析
智能评审

Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events

被引：11
作者：
Rodondi, N
Bauer, DC
机构：
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, Prevent Sci Grp, San Francisco, CA 94105 USA
[2] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94105 USA
来源：
AMERICAN JOURNAL OF MEDICINE | 2004年 / 117卷 / 07期
关键词：
D O I：
10.1016/j.amjmed.2004.07.037
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：528 / 530
页数：3
相关论文
共 18 条
  • [1] The Framingham prediction rule is not valid in a European population of treated hypertensive patients
    Bastuji-Garin, S
    Deverly, A
    Moyse, D
    Castaigne, A
    Mancia, G
    de Leeuw, PW
    Ruilope, LM
    Rosenthal, T
    Chatellier, G
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 (10) : 1973 - 1980
  • [2] Aspirin for the primary prevention of cardiovascular events: Recommendation and rationale
    Berg, AO
    Allan, JD
    Frame, PS
    Homer, CJ
    Johnson, MS
    Klein, JD
    Lieu, TA
    Mulrow, CD
    Orleans, CT
    Peipert, JF
    Pender, NJ
    Siu, AL
    Teutsch, SM
    Westhoff, C
    Woolf, SH
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (02) : 157 - 160
  • [3] Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
    Conroy, RM
    Pyörälä, K
    Fitzgerald, AP
    Sans, S
    Menotti, A
    De Backer, G
    De Bacquer, D
    Ducimetière, P
    Jousilahti, P
    Keil, U
    Njolstad, I
    Oganov, RG
    Thomsen, T
    Tunstall-Pedoe, H
    Tverdal, A
    Wedel, H
    Whincup, P
    Wilhelmsen, L
    Graham, IM
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (11) : 987 - 1003
  • [4] Primary prevention of coronary heart disease - Integrating risk assessment with intervention
    Grundy, SM
    [J]. CIRCULATION, 1999, 100 (09) : 988 - 998
  • [5] Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial
    Hansson, L
    Zanchetti, A
    Carruthers, SG
    Dahlöf, B
    Elmfeldt, D
    Julius, S
    Ménard, J
    Rahn, KH
    Wedel, H
    Westerling, S
    [J]. LANCET, 1998, 351 (9118) : 1755 - 1762
  • [6] Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the US Preventive Services Task Force
    Hayden, M
    Pignone, M
    Phillips, C
    Mulrow, C
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (02) : 161 - 172
  • [7] Aspirin and risk of hemorrhagic stroke - A meta-analysis of randomized controlled trials
    He, J
    Whelton, PK
    Vu, B
    Klag, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (22): : 1930 - 1935
  • [8] FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY
    HENNEKENS, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) : 129 - 135
  • [9] Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study
    Liu, J
    Hong, YL
    D'Agostino, RB
    Wu, ZS
    Wang, W
    Sun, JY
    Wilson, PWF
    Kannel, WB
    Zhao, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (21): : 2591 - 2599
  • [10] Application of US guidelines in other countries: Aspirin for the primary prevention of cardiovascular events in Japan
    Morimoto, T
    Fukui, T
    Lee, TH
    Matsui, K
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 117 (07) : 459 - 468
12